BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7413018)

  • 1. Effect of chronic intracerebroventricular angiotensin II infusion on vasopressin release in rats.
    Sterling GH; Chee O; Riggs RV; Keil LC
    Neuroendocrinology; 1980 Sep; 31(3):182-8. PubMed ID: 7413018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin, fluid, and electrolyte response to chronic angiotensin II infusion.
    Cowley AW; Switzer SJ; Skelton MM
    Am J Physiol; 1981 Mar; 240(3):R130-8. PubMed ID: 7212084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracerebroventricular deuterium oxide on water intake and AVP release induced by intravenous infusion of angiotensin II in sheep.
    Hjelmqvist H; Rundgren M
    Acta Physiol Scand; 1990 Feb; 138(2):155-60. PubMed ID: 2156405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium depletion and angiotensin II on osmotic regulation of vasopressin.
    Wade CE; Keil LC; Ramsay DJ
    Am J Physiol; 1986 Feb; 250(2 Pt 2):R287-91. PubMed ID: 3946642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
    Kimura T; Abe K; Ota K; Omata K; Shoji M; Kudo K; Matsui K; Inoue M; Yasujima M; Yoshinaga K
    J Clin Endocrinol Metab; 1986 May; 62(5):1003-10. PubMed ID: 2937798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral sodium/angiotensin interaction studied by RIA-determination of urinary arginine vasopressin in the hydrated goat.
    Lishajko F; Appelgren B; Eriksson S
    Acta Physiol Scand; 1981 Mar; 111(3):311-8. PubMed ID: 7315399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterium induced extinction of ADH-release in response to intracerebroventricular infusions of hypertonic NaCl and angiotensin.
    Rundgren M; Leksell LG; Lishajko F; Andersson B
    Acta Physiol Scand; 1977 May; 100(1):45-50. PubMed ID: 899828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T; Oki Y; Orth DN
    Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women.
    Stachenfeld NS; DiPietro L; Palter SF; Nadel ER
    Am J Physiol; 1998 Jan; 274(1):R187-95. PubMed ID: 9458917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for the subfornical organ in vasopressin release.
    Mangiapane ML; Thrasher TN; Keil LC; Simpson JB; Ganong WF
    Brain Res Bull; 1984 Jul; 13(1):43-7. PubMed ID: 6478269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is vasopressin an important hypertensive hormone?
    Lohmeier TE; Smith MJ; Cowley AW; Manning RD; Guyton AC
    Hypertension; 1981; 3(4):416-25. PubMed ID: 7309205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic thirst and vasopressin release in humans: a double-blind crossover study.
    Phillips PA; Rolls BJ; Ledingham JG; Forsling ML; Morton JJ
    Am J Physiol; 1985 Jun; 248(6 Pt 2):R645-50. PubMed ID: 4003573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypertonic saline causes transient fall of vasopressin in humans.
    Seckl JR; Williams TD; Lightman SL
    Am J Physiol; 1986 Aug; 251(2 Pt 2):R214-7. PubMed ID: 3740301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragastric hypertonic saline increases vasopressin and central Fos immunoreactivity in conscious rats.
    Carlson SH; Beitz A; Osborn JW
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R750-8. PubMed ID: 9087636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H; Watanabe K
    Eur J Endocrinol; 1996 Feb; 134(2):243-50. PubMed ID: 8630527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic physiological increases in cortisol inhibit the vasopressin response to hypertonicity in conscious dogs.
    Papanek PE; Raff H
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1342-9. PubMed ID: 7977863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic intraventricular administration of angiotensin II on drinking behavior and blood pressure.
    Gronan RJ; York DH
    Pharmacol Biochem Behav; 1979 Jan; 10(1):121-6. PubMed ID: 441088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role of angiotensin in the hyperosmolality- and hypovolaemia-induced vasopressin release in conscious rats.
    Yamaguchi K; Sakaguchi T; Kamoi K
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):524-30. PubMed ID: 7158228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.